- About this Journal
- Abstracting and Indexing
- Aims and Scope
- Annual Issues
- Article Processing Charges
- Articles in Press
- Author Guidelines
- Bibliographic Information
- Citations to this Journal
- Contact Information
- Editorial Board
- Editorial Workflow
- Free eTOC Alerts
- Publication Ethics
- Reviewers Acknowledgment
- Submit a Manuscript
- Subscription Information
- Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 856265, 9 pages
Genome Diversification Mechanism of Rodent and Lagomorpha Chemokine Genes
1School of Health Sciences, Kumamoto University, Kuhonji, Kumamoto 860-0976, Japan
2Department of Molecular Enzymology, Kumamoto University, Graduate School of Medical Sciences, Honjo, Kumamoto 860-8556, Japan
3Department of Microbiology, Kinki University, Faculty of Medicine, Osaka-Sayama, Osaka 589-8511, Japan
4Department of Biomedical Laboratory Sciences, Faculty of Life Sciences, Kumamoto University, Kuhonji, Kumamoto 860-0976, Japan
Received 23 April 2013; Accepted 11 July 2013
Academic Editor: Sanford I. Bernstein
Copyright © 2013 Kanako Shibata et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- B. Moser, M. Wolf, A. Walz, and P. Loetscher, “Chemokines: multiple levels of leukocyte migration control,” Trends in Immunology, vol. 25, no. 2, pp. 75–84, 2004.
- A. Zlotnik and O. Yoshie, “Chemokines: a new classification system and their role in immunity,” Immunity, vol. 12, no. 2, pp. 121–127, 2000.
- A. Zlotnik and O. Yoshie, “The chemokine superfamily revisited,” Immunity, vol. 36, no. 5, pp. 705–716, 2012.
- H. Nomiyama, N. Osada, and O. Yoshie, “Systematic classification of vertebrate chemokines based on conserved synteny and evolutionary history,” Genes to Cells, vol. 18, no. 1, pp. 1–16, 2013.
- K. J. Laing and C. J. Secombes, “Chemokines,” Developmental and Comparative Immunology, vol. 28, no. 5, pp. 443–460, 2004.
- H. Nomiyama, K. Hieshima, N. Osada et al., “Extensive expansion and diversification of the chemokine gene family in zebrafish: identification of a novel chemokine subfamily CX,” BMC Genomics, vol. 9, article 222, 2008.
- H. Nomiyama, N. Osada, and O. Yoshie, “The evolution of mammalian chemokine genes,” Cytokine and Growth Factor Reviews, vol. 21, no. 4, pp. 253–262, 2010.
- A. Mantovani, R. Bonecchi, and M. Locati, “Tuning inflammation and immunity by chemokine sequestration: decoys and more,” Nature Reviews Immunology, vol. 6, no. 12, pp. 907–918, 2006.
- A. Mantovani, “The chemokine system: redundancy for robust outputs,” Immunology Today, vol. 20, no. 6, pp. 254–257, 1999.
- R. Colobran, E. Pedrosa, L. Carretero-Iglesia, and M. Juan, “Copy number variation in chemokine superfamily: the complex scene of CCL3L-CCL4L genes in health and disease,” Clinical and Experimental Immunology, vol. 162, no. 1, pp. 41–52, 2010.
- H. Nakano and M. D. Gunn, “Gene duplications at the chemokine locus on mouse chromosome 4: multiple strain-specific haplotypes and the deletion of secondary lymphoid-organ chemokine and EBI-1 ligand chemokine genes in the plt mutation,” Journal of Immunology, vol. 166, no. 1, pp. 361–369, 2001.
- E. Gonzalez, H. Kulkarni, H. Bolivar et al., “The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility,” Science, vol. 307, no. 5714, pp. 1434–1440, 2005.
- J. D. Degenhardt, P. De Candia, A. Chabot et al., “Copy number variation of CCL3-like genes affects rate of progression to simian-AIDS in rhesus macaques (Macaca mulatta),” PLoS Genetics, vol. 5, no. 1, Article ID e1000346, 2009.
- L. Shostakovich-Koretskaya, G. Catano, Z. A. Chykarenko et al., “Combinatorial content of CCL3L and CCL4L gene copy numbers influence HIV-AIDS susceptibility in Ukrainian children,” AIDS, vol. 23, no. 6, pp. 679–688, 2009.
- H. Nomiyama, N. Osada, and O. Yoshie, “A family tree of vertebrate chemokine receptors for a unified nomenclature,” Developmental and Comparative Immunology, vol. 35, no. 7, pp. 705–715, 2011.
- M. J. Benton and P. C. J. Donoghue, “Paleontological evidence to date the tree of life,” Molecular Biology and Evolution, vol. 24, no. 1, pp. 26–53, 2007.
- H. Nomiyama, A. Mera, O. Ohneda, R. Miura, T. Suda, and O. Yoshie, “Organization of the chemokine genes in the human and mouse major clusters of CC and CXC chemokines: diversification between the two species,” Genes and Immunity, vol. 2, no. 2, pp. 110–113, 2001.
- C. Zhang, P. Gadue, E. Scott, M. Atchison, and M. Poncz, “Activation of the megakaryocyte-specific gene protein (PBP) by the Ets family factor PU.1,” Journal of Biological Chemistry, vol. 272, no. 42, pp. 26236–26246, 1997.
- R. L. Shattuck-Brandt, L. D. Wood, and A. Richmond, “Identification and characterization of an MGSA/GRO pseudogene,” Mitochondrial DNA, vol. 7, no. 6, pp. 379–386, 1997.
- W. S. Modi and T. Yoshimura, “Isolation of novel GRO genes and a phylogenetic analysis of the CXC chemokine subfamily in mammals,” Molecular Biology and Evolution, vol. 16, no. 2, pp. 180–193, 1999.
- A. Zlotnik, O. Yoshie, and H. Nomiyama, “The chemokine and chemokine receptor superfamilies and their molecular evolution,” Genome Biology, vol. 7, no. 12, article 243, 2006.
- C. Chavey, G. Lazennec, S. Lagarrigue et al., “CXC ligand 5 is an adipose-tissue derived factor that links obesity to insulin resistance,” Cell Metabolism, vol. 9, no. 4, pp. 339–349, 2009.
- J. Van Damme, A. Wuyts, G. Froyen et al., “Granulocyte chemotactic protein-2 and related CXC chemokines: from gene regulation to receptor usage,” Journal of Leukocyte Biology, vol. 62, no. 5, pp. 563–569, 1997.
- X. Fan, A. C. Patera, A. Pong-Kennedy et al., “Murine CXCR1 is a functional receptor for GCP-2/CXCL6 and interleukin-8/CXCL8,” Journal of Biological Chemistry, vol. 282, no. 16, pp. 11658–11666, 2007.
- P. M. Murphy, “Molecular mimicry and the generation of host defense protein diversity,” Cell, vol. 72, no. 6, pp. 823–826, 1993.
- G. McFadden and P. M. Murphy, “Host-related immunomodulators encoded by poxviruses and herpesviruses,” Current Opinion in Microbiology, vol. 3, no. 4, pp. 371–378, 2000.
- J. M. Boomker, L. F. M. H. de Leij, T. H. The, and M. C. Harmsen, “Viral chemokine-modulatory proteins: tools and targets,” Cytokine and Growth Factor Reviews, vol. 16, no. 1, pp. 91–103, 2005.
- R. Colobran, R. Pujol-Borrell, M. P. Armengol, and M. Juan, “The chemokine network. I. How the genomic organization of chemokines contains clues for deciphering their functional complexity,” Clinical and Experimental Immunology, vol. 148, no. 2, pp. 208–217, 2007.
- R. Colobran, P. Adreani, Y. Ashhab et al., “Multiple products derived from two CCL4 Loci: high incidence of a new polymorphism in HIV+ patients,” Journal of Immunology, vol. 174, no. 9, pp. 5655–5664, 2005.
- M. Hirashima, T. Ono, M. Nakao et al., “Nucleotide sequence of the third cytokine LD78 gene and mapping of all three LD78 gene loci to human chromosome 17,” DNA Sequence, vol. 3, no. 4, pp. 203–212, 1992.
- H. Nomiyama, K. Egami, S. Tanase et al., “Comparative DNA sequence analysis of mouse and human CC chemokine gene clusters,” Journal of Interferon and Cytokine Research, vol. 23, no. 1, pp. 37–45, 2003.
- S. Fukuda, Y. Hanano, M. Iio, R. Miura, O. Yoshie, and H. Nomiyama, “Genomic organization of the genes for human and mouse CC chemokine LEC,” DNA and Cell Biology, vol. 18, no. 4, pp. 275–283, 1999.
- S. A. Islam, D. S. Chang, R. A. Colvin et al., “Mouse CCL8, a CCR8 agonist, promotes atopic dermatitis by recruiting IL-5+2 cells,” Nature Immunology, vol. 12, no. 2, pp. 167–177, 2011.
- P. Menten, A. Wuyts, and J. Van Damme, “Macrophage inflammatory protein-1,” Cytokine and Growth Factor Reviews, vol. 13, no. 6, pp. 455–481, 2002.
- S. G. Irving, P. F. Zipfel, J. Balke et al., “Two inflammatory mediator cytokine genes are closely linked and variably amplified on chromosome 17q,” Nucleic Acids Research, vol. 18, no. 11, pp. 3261–3270, 1990.
- M. Nakao, H. Nomiyama, and K. Shimada, “Structures of human genes coding for cytokine LD78 and their expression,” Molecular and Cellular Biology, vol. 10, no. 7, pp. 3646–3658, 1990.
- Y. Tasaki, S. Fukuda, I. Masayoshi et al., “Chemokine PARC gene (SCYA18) generated by fusion of two MIP-1α/LD78α- like genes,” Genomics, vol. 55, no. 3, pp. 353–357, 1999.
- E. Schutyser, A. Richmond, and J. Van Damme, “Involvement of CC chemokine ligand 18 (CCL18) in normal and pathological processes,” Journal of Leukocyte Biology, vol. 78, no. 1, pp. 14–26, 2005.
- O. Yoshie, T. Imai, and H. Nomiyama, “Novel lymphocyte-specific CC chemokines and their receptors,” Journal of Leukocyte Biology, vol. 62, no. 5, pp. 634–644, 1997.
- O. Yoshie, T. Imai, and H. Nomiyama, “Chemokines in immunity,” Advances in Immunology, vol. 78, pp. 57–110, 2001.
- S. M. Pope, P. C. Fulkerson, C. Blanchard et al., “Identification of a cooperative mechanism involving interleukin-13 and eotaxin-2 in experimental allergic lung inflammation,” Journal of Biological Chemistry, vol. 280, no. 14, pp. 13952–13961, 2005.
- C. Blanchard, N. Wang, K. F. Stringer et al., “Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis,” Journal of Clinical Investigation, vol. 116, no. 2, pp. 536–547, 2006.
- T. Nagasawa, S. Hirota, K. Tachibana et al., “Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1,” Nature, vol. 382, no. 6592, pp. 635–638, 1996.
- M. O. Huising, R. J. M. Stet, C. P. Kruiswijk, H. F. J. Savelkoul, and B. M. Lidy Verburg-van Kemenade, “Molecular evolution of CXC chemokines: extant CXC chemokines originate from the CNS,” Trends in Immunology, vol. 24, no. 6, pp. 306–312, 2003.
- M. E. DeVries, A. A. Kelvin, L. Xu, L. Ran, J. Robinson, and D. J. Kelvin, “Defining the origins and evolution of the chemokine/chemokine receptor system,” Journal of Immunology, vol. 176, no. 1, pp. 401–415, 2006.
- D. C. Shields, “Gene conversion among chemokine receptors,” Gene, vol. 246, no. 1-2, pp. 239–245, 2000.
- P. M. Murphy, M. Baggiolini, I. F. Charo et al., “International union of pharmacology. XXII. Nomenclature for chemokine receptors,” Pharmacological Reviews, vol. 52, no. 1, pp. 145–176, 2000.
- J. Chen, Y. Yao, C. Gong et al., “CCL18 from tumor-associated macrophages promotes breast cancer metastasis via PITPNM3,” Cancer Cell, vol. 19, no. 4, pp. 541–555, 2011.